Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR) Shares Surge on Ebola drug development: U.S. Daily Market Movers

Published:

Small
cap stocks making big moves on Friday, August 8, 2014 (as of 4 pm EST)

Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR)
shares shot up 45% to $20.70 on volume of more than 28 million shares Friday
after the Canadian biopharmaceutical company said the U.S. FDA is moving closer
to approving its anti-Ebola drug.  

As well,
shares of Marrone Bio Innovations, Inc.
(NASDAQ:
MBII
) plunged 42% to $5.51 as the provider of bio-based pest management and
plant health products announced that its Chief Operating Officer had resigned
for personal reasons and reported a drop in its Q2 revenue to $3.6 million from
$4.5 million.

China HGS Real Estate Inc. (NASDAQ: HGSH),
meanwhile, reported a more than 300% year-over-year Q3 revenue increase, while
earnings per share for the period jumped 260% year-over-year to 18 cents from 5
cents. China HGS Real Estate stock popped 42% to $3.17 following the
announcement.

Finally,
Raptor Pharmaceutical Corp. (NASDAQ: RPTP)
shares climbed 28% to $10.56 after the biopharmaceutical company increased its
net product sales guidance for PROCYSBI to a range of $65 million to $70
million for 2014, up from $55 million to $65 million. PROCYSBI is used for the
management of nephropathic cystinosis.  

Related articles

Recent articles